Basit öğe kaydını göster

dc.contributor.authorGazioglu, Nurperi
dc.contributor.authorKADIOĞLU, Pınar
dc.contributor.authorKameda, Hiraku
dc.contributor.authorTANRIÖVER, Necmettin
dc.contributor.authorOzturk, Melek
dc.contributor.authorMetin-Armagan, Derya
dc.contributor.authorÇOMUNOĞLU, Nil
dc.contributor.authorBULUT, GÜLAY
dc.date.accessioned2021-03-03T16:09:17Z
dc.date.available2021-03-03T16:09:17Z
dc.date.issued2020
dc.identifier.citationMetin-Armagan D., ÇOMUNOĞLU N., BULUT G., KADIOĞLU P., Kameda H., Gazioglu N., TANRIÖVER N., Ozturk M., "A Novel Expression Profile of Cell Cycle and DNA Repair Proteins in Nonfunctioning Pituitary Adenomas", ENDOCRINE PATHOLOGY, cilt.31, sa.1, ss.2-13, 2020
dc.identifier.issn1046-3976
dc.identifier.othervv_1032021
dc.identifier.otherav_42ac8df7-1663-44a7-aa55-30958fd938c8
dc.identifier.urihttp://hdl.handle.net/20.500.12627/48553
dc.identifier.urihttps://doi.org/10.1007/s12022-019-09598-x
dc.description.abstractThe molecular mechanisms underlying the formation of nonfunctioning pituitary adenomas (NFAs) are largely unknown. In this study, we aimed to understand the relationship between NFAs and functional pituitary adenomas and the possible role of proteins involved in cell cycle, senescence, and DNA damage control mechanisms in the etiology of NFA. We analyzed pATM-S1981, pRb-S608, Rb, pE2F1-S364, p16, E2F1, p73, cyclin D1, and CHEK2 protein expression (in a group of 20 patients with acromegaly, 18 patients with Cushing's disease (CD), and 29 NFA patients) by immunohistochemistry and their relevant mRNA expression by qRT-PCR (in a group of 7 patients with acromegaly, 7 patients with CD, and 7 NFA patients). The clinical and histopathological results on the patients were statistically evaluated. pE2F1-S364 protein expression in the CD group was significantly lower than that in the NFA and acromegaly groups (p = 0.025, p = 0.034, respectively). However, the expression of the p16 protein was lower than in the NFA group than in the CD and acromegaly groups (p = 0.030, p = 0.033, respectively), and E2F1 protein expression was significantly higher in the NFA group than in the CD group (p = 0.025). p73 protein expression in patients with acromegaly was significantly higher (p = 0.031) than that in the CD group. CHEK2 mRNA expression in the CD group was significantly higher than that in the acromegaly group (p = 0.012). The selective and tumor-specific associations between E2F1, pE2F1-S364, CHEK2, and p73 mRNA and protein levels indicate their involvement in pituitary adenoma formation in NFA, CD, and acromegaly patients.
dc.language.isoeng
dc.subjectTemel Tıp Bilimleri
dc.subjectBiyokimya
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.subjectCerrahi Tıp Bilimleri
dc.subjectPatoloji
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectBiyoloji ve Biyokimya
dc.subjectPATOLOJİ
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.titleA Novel Expression Profile of Cell Cycle and DNA Repair Proteins in Nonfunctioning Pituitary Adenomas
dc.typeMakale
dc.relation.journalENDOCRINE PATHOLOGY
dc.contributor.departmentİstanbul Üniversitesi-Cerrahpaşa , ,
dc.identifier.volume31
dc.identifier.issue1
dc.identifier.startpage2
dc.identifier.endpage13
dc.contributor.firstauthorID2278604


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster